Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Showing 20 of 0 results

Not applicableUnknownNCT03789513
What this trial is testing

Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected Women

Who this might be right for
HIV InfectionsHPV - Anogenital Human Papilloma Virus Infection
ANRS, Emerging Infectious Diseases 3,000
Early research (Phase 1)Study completedNCT00038480
What this trial is testing

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Testing effectiveness (Phase 2)Study completedNCT02251223
What this trial is testing

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 208
Not applicableStudy completedNCT01446718
What this trial is testing

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

Who this might be right for
Human PapillomavirusHIV-1 Infection
Kenya Medical Research Institute 179
Not applicableStudy completedNCT00002173
What this trial is testing

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

Who this might be right for
HIV Infections
The Immune Response Corporation
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)Ended earlyNCT00824369
What this trial is testing

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

Who this might be right for
HIV-1
Pfizer 52
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Not applicableUnknownNCT05140603
What this trial is testing

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Who this might be right for
Hiv
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 150
Early research (Phase 1)Study completedNCT01479361
What this trial is testing

Antiretroviral Drug Interaction Study in Volunteers With HIV

Who this might be right for
HIVPCPToxoplasmosis
National Institutes of Health Clinical Center (CC) 36
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Large-scale testing (Phase 3)Study completedNCT02660905
What this trial is testing

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Who this might be right for
Human Immunodeficiency VirusHepatitis C, Chronic
Ottawa Hospital Research Institute 25
Not applicableStudy completedNCT01886404
What this trial is testing

EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients

Who this might be right for
HIV Infection
University of Nebraska 30
Post-approval studies (Phase 4)Study completedNCT02547844
What this trial is testing

Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With Atripla

Who this might be right for
HIV-1
Hospital Universitari Vall d'Hebron Research Institute 30
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00001133
What this trial is testing

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableUnknownNCT01687504
What this trial is testing

Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana

Who this might be right for
TuberculosisHIV
The Miriam Hospital 106
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation